Mach5 Therapeutics, Inc. — Form D
Mach5 Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-04. The offering totals $19.9M, of which $19.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-04
- Form: D
- Accession: 0001493152-24-043506
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.9M
- Amount sold: $19.2M
- Remaining: $750K
- Investors: 15
- Date of first sale: 2024-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528600
Issuer
- Name: Mach5 Therapeutics, Inc.
- CIK: 0002018014
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 650 PONCE DE LEON AVE, ATLANTA, GA, 30308
- Phone: 404-487-8769
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Patrick J Crutcher | Director | Atlanta, GA |
| Justin J DiMartino | Director | Atlanta, GA |
| Patrick J Crutcher | Executive Officer | Atlanta, GA |
| Justin J DiMartino | Executive Officer | Atlanta, GA |
| Justin J DiMartino | Promoter | Atlanta, GA |
| Patrick J Crutcher | Promoter | Atlanta, GA |
Other filings by this issuer (2)
More